CYTOKINETICS, INCORPORATED Equity Securities, FV-NI, Unrealized Gain (Loss)
CYTOKINETICS, INCORPORATED (CYTK) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of $500.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2021-02-26
- CYTOKINETICS, INCORPORATED equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2020-09-30 was $500.00K.
- CYTOKINETICS, INCORPORATED equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2020-06-30 was $700.00K.
- CYTOKINETICS, INCORPORATED equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2020-03-31 was -$400.00K.
- CYTOKINETICS, INCORPORATED equity securities, fv-ni, unrealized gain (loss) for fiscal 2019 was $300.00K, a 200.00% increase from fiscal 2018.
- CYTOKINETICS, INCORPORATED equity securities, fv-ni, unrealized gain (loss) for fiscal 2018 was $100.00K.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 6 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2020-09-30 | $500.00K 10-Q · filed 2020-11-06 | $1.20M derived: sum of 2 quarters · filed 2020-11-06 | $900.00K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $700.00K 10-Q · filed 2020-08-07 | $300.00K 10-Q · filed 2020-08-07 | ||
| 2020-03-31 | -$400.00K 10-Q · filed 2020-05-08 | |||
| 2019-12-31 | $300.00K 10-K · filed 2021-02-26 | |||
| 2018-12-31 | $100.00K 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |